MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Cancer Genetics Company Profile (NASDAQ:CGIX)

Consensus Ratings for Cancer Genetics (NASDAQ:CGIX) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $15.00 (600.93% upside)

Analysts' Ratings History for Cancer Genetics (NASDAQ:CGIX)
Show:
DateFirmActionRatingPrice TargetActions
3/15/2016AegisBoost Price TargetBuy$8.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2016Janney Montgomery ScottReiterated RatingBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015Cantor FitzgeraldReiterated RatingBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha